Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

Share Price is delayed by 15 minutes
Get Live Data
1,137.50    20.50 (1.84%)
Bid:
1,129.50
Ask:
1,132.50
Spread: 3.00 (0.266%)
Market Cap: £4.09b
BRBY Live PriceLast checked at - London Stock Exchange

Intraday Burberry Share Chart

Board Change

23 Sep 2022 09:36

RNS Number : 4520A
Burberry Group PLC
23 September 2022
 

Burberry Group plc

("Burberry" or the "Company")

Board Change

 

Burberry today announces that Julie Brown has notified the Board of her intention to step down as Chief Operating and Financial Officer at the close of the Company's current financial year on 1 April 2023.

 

Julie will be leaving Burberry after six years to take up an opportunity outside of the luxury industry. The process to identify Julie's successor is underway and further updates will be announced in due course.

Gerry Murphy, Chair, commented: "On behalf of the Board, I would like to thank Julie for her very significant contribution to Burberry's transformation, including her central role in delivering our sustainability ambitions. Julie has built a strong financial base for the next chapter of Burberry's growth under Jonathan's leadership."

 

Jonathan Akeroyd, CEO, commented: "Julie has played a key role in positioning Burberry for growth, supported by a high-quality team. I would like to personally thank her for the support she has provided me since I joined six months ago. I look forward to building on the strong foundations we have in place to realise Burberry's full potential."

 

Julie Brown, CO&FO, commented: "It has been a privilege to serve as Burberry's CO&FO. As a group, we have strengthened our brand and business and taken an industry-leading position in sustainability. I am particularly proud of our work to navigate Burberry through the pandemic, remaining true to our values and delivering transformational change across Finance, IT, Burberry Business Services and Responsibility. I would like to thank Gerry, Jonathan, the Board, my colleagues and above all my team for their partnership. I am fully committed to continuing to support them until the close of our financial year."

 

Remuneration information:

 

Julie will be treated in accordance with Burberry's shareholder-approved remuneration policy and her service contract for the remaining term of her employment. All share awards which are unvested at the point that Julie leaves Burberry will lapse in full. No further share awards will be granted.

 

Full details will be disclosed on Burberry's website in compliance with Section 430(2B) of the Companies Act 2006 and in the Directors' Remuneration Report within the Company's Annual Report and Accounts for FY2022/23.

 

This announcement contains inside information and is made on behalf of the Company by Gemma Parsons, Company Secretary. 

 

 

23 September 2022

 

 

Enquiries

 

Investors and analysts

Julian Easthope

VP, Investor Relations

020 3367 4458

julian.easthope@burberry.com

 

Media

Andrew Roberts

 

 

SVP, Corporate Relations and Engagement

 

 

020 3367 3764

andrew.roberts@burberry.com

 

 

About Burberry

· Founded in 1856, Burberry is a British luxury brand, headquartered in London

· Burberry is listed on the London Stock Exchange (BRBY.L) and is a constituent of the FTSE 100 index. Its ADR symbol is OTC:BURBY.

· BURBERRY, the Equestrian Knight Device, the Burberry Check and the Thomas Burberry Monogram and Print are trademarks belonging to Burberry.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOALJMPTMTJTMJT
Date   Source Headline
10th Jun 20264:52 pmRNSDirector Declaration
9th Jun 202611:30 amRNSHolding(s) in Company
1st Jun 202610:15 amRNSIssue of Shares & Total Voting Rights
28th May 202610:45 amRNSAnnual Financial Report
14th May 20267:01 amRNSBoard changes
14th May 20267:00 amRNSBurberry FY26 Preliminary Results
1st May 202612:20 pmRNSIssue of Shares & Total Voting Rights
29th Apr 20262:45 pmRNSDirector Declaration
10th Apr 20263:40 pmRNSHolding(s) in Company
9th Apr 202611:30 amRNSHolding(s) in Company
1st Apr 20265:30 pmRNSIssue of Shares & Total Voting Rights
1st Apr 202612:15 pmRNSHolding(s) in Company
20th Mar 202612:31 pmRNSDirector/PDMR Shareholding
20th Mar 202610:25 amRNSIssue of Equity
19th Mar 20266:00 pmRNSHolding(s) in Company
5th Mar 20264:40 pmRNSHolding(s) in Company
2nd Mar 202611:00 amRNSTotal Voting Rights
12th Feb 20262:00 pmRNSHolding(s) in Company
10th Feb 202610:30 amRNSHolding(s) in Company
2nd Feb 20262:00 pmRNSTotal Voting Rights
27th Jan 20265:00 pmRNSHolding(s) in Company
22nd Jan 202612:30 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSThird Quarter Trading Update
9th Jan 202612:30 pmRNSHolding(s) in Company
2nd Jan 202611:30 amRNSTotal Voting Rights
18th Dec 20252:01 pmRNSHolding(s) in Company
18th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20259:15 amRNSDirector/PDMR Shareholding
2nd Dec 20255:40 pmRNSHolding(s) in Company
1st Dec 20251:30 pmRNSTotal Voting Rights
24th Nov 20255:30 pmRNSHolding(s) in Company
20th Nov 20254:20 pmRNSHolding(s) in Company
19th Nov 20255:36 pmRNSHolding(s) in Company
18th Nov 20256:07 pmRNSHolding(s) in Company
13th Nov 20255:27 pmRNSHolding(s) in Company
13th Nov 20257:00 amRNSBurberry Interim Results
3rd Nov 20252:43 pmRNSTotal Voting Rights
28th Oct 20254:50 pmRNSHolding(s) in Company
15th Oct 20255:38 pmRNSHolding(s) in Company
10th Oct 202512:07 pmRNSHolding(s) in Company
2nd Oct 20253:10 pmRNSHolding(s) in Company
1st Oct 202510:30 amRNSTotal Voting Rights
25th Sep 20256:00 pmRNSHolding(s) in Company
5th Sep 20256:21 pmRNSBlock listing Interim Review
5th Sep 20255:45 pmRNSDirector/PDMR Shareholding
1st Sep 202512:14 pmRNSTotal Voting Rights
13th Aug 20253:04 pmRNSHolding(s) in Company
1st Aug 202511:58 amRNSTotal Voting Rights
31st Jul 20254:55 pmRNSDirector/PDMR Shareholding
18th Jul 20255:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.